Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 1 day agoThe agency will now take the committee’s advice under consideration as it decides whether to approve...
FDA To Review New Alzheimer's Drug Leqembi and How Often Patients Get Medication
Healthline via AOL· 14 hours agoA medication designed to slow early Alzheimer’s disease may soon have a new once-a-month dosing...
New breakthrough Alzheimer’s drug gets unanimous backing from FDA advisers
NY Post via Yahoo News· 2 days agoThe vote clears the way for a final FDA decision on the treatment, which initially had been expected...
FDA panel backs new Alzheimer's drug, Apple unveils new AI and iOS features and Warner Bros....
The Yodel via Yahoo News· 2 days agoGet caught up on this morning’s news: A new Alzheimer’s drug, the ‘Practical Magic’ sequel and more...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 1 day agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
USA TODAY via Yahoo News· 2 days ago"Donanemab...said. "But it could be part of an effective cocktail, and we've got to start somewhere." Last year, the FDA approved Eisai and Biogen's < ...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 1 day agoImage Source: Zacks Investment Research Approval of new drugs and label expansion of the existing...
A guide to safe US sunscreens – and the ingredients to avoid
The Guardian via Yahoo News· 10 hours agoSunscreen use has aesthetic benefits too...sunscreen ingredients have been classified as safe and...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 6 days agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters via Yahoo News· 7 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...